P311 is an 8-kDa intracellular protein that is highly conserved across species and is expressed in the nervous sysem as well as in vascular and visceral smooth muscle cells. P311-null (P311 ) mice display learning and memory defects, but alterations in their vasculature have not been previously described. Here we report that P311 mice are markedly hypotensive with accompanying defects in vascular tone and VSMC contractility. Functional abnormalities in P311 mice resulted from decreased total and active levels of TGF-β1, TGF-β2, and TGF-β3 that arise as a specifc consequence of decreased translation. Vascular hypofunctionality was fully rescued in vitro and in vivo by exogenous TGF-β1-TGF-β3. Conversely, P311-transgenic (P311 ) mice had elevated levels of TGF-β1-TGF-β3 and subsequent hypertension.
 Introduction P311 is an 8-kDa intracellular protein that is highly conserved across species and is normally expressed in the nervous sysem and in vascular and visceral smooth muscle beds. In addition, P311 is detected in myofbroblass (1), at the invading edge of glioblasomas (2), in regenerating nerve and lung (3, 4) , and in hypertrophic scars (5). P311 has been implicated in myofbroblas diferentiation as well as nerve and lung regeneration (3, 4) . Although it neither belongs to any esablished protein family nor possesses signature motifs that sugges function, P311
features a conserved PEST (rich in proline [P] , glutamic acid [D] , aspartic acid [E] , and serine [S] or threonine [T])-like amino acid sequence at the N terminus (6). PEST motifs were originally identifed in short-lived proteins as targets for ubiquitin-proteasome degradation (7) and subsequently found to mediate protein-protein interactions and activation (8) (9) (10) (11) (12) (13) (14) . Although deletion of P311 in mice results in no overt phenotype (15) , P311 mice display learning and memory defects, consisent with the presence of P311 in the nervous sysem (15, 16) .
TGF-βs are multifunctional growth factors capable of inducing a spectrum of cellular events, including proliferation, cell cycle arres, diferentiation, programmed cell death, and simulation of matrix deposition (17) (18) (19) . TGF-βs are synthesized as a large homodimeric precursor (pro-TGF-β) that is cleaved into mature TGF-β and latent-associated protein (LAP), which remain noncovalently associated (20, 21) . Before TGF-βs can exert their biological efects, they mus dissociate from LAP in order to become active (20, 21) . Active TGF-βs signal through TGF-β receptors I and II and the transcriptional coregulators . Upon phosphorylation (i.e., activation), Smad2 and Smad3 bind to Smad4, translocate to the nucleus, and bind to the CAGA box (found in the promoters of multiple refs. 25, 26) to activate their transcription (22) (23) (24) . Smad-independent pathways had been also identifed (22, 23) .
Because P311 is also expressed at high levels in VSMCs (1, 6), we explored its potential role within the sysemic vasculature. Here, we found that P311 mice were markedly hypotensive, with accompanying defects in vascular tone and VSMC contractility. Functional abnormalities -/--/-in P311 mice resulted from decreased translation of TGF-β, which decreased the level and activity of TGF-βs. Conversely, mice overexpressing P311 showed an elevation in level and activity of TGF-βs as well as sysemic hypertension. Consisent with these fndings, arteries from hypertensive humans displayed increased P311 expression. In summary, our sudies identifed P311 as the frs regulator of TGF-βs translation with a critical role in blood pressure control. expression levels were higher in arteries than in veins (Supplemental Figure 1D ). Morphometry did not show diferences between P311 and WT mice (Supplemental Figure 1 , E and F). Telemetric determination revealed diurnal sysolic and diasolic blood pressures to be 16.5 ± 3 and 14 ± 5 mmHg lower, respectively, in P311 mice than in WT mice, with slightly increased nocturnal diferences ( Figure 1A) . Echocardiographic sudies performed in conscious mice revealed enlarged aortic diameter in P311 animals that disappeared under general aneshesia ( Figure 1B ).
There were no signifcant diferences in other echocardiographic parameters, except for increased cardiac output (Supplemental Figure   2 ). Together, these fndings suggesed a decrease in myogenic tone, which was confrmed by pressure myography using resisance arteries ( 150 μm in diameter) ( Figure 1C and Supplemental Figure 3 ).
Myographic sudies on isolated aortas showed decreased contractility in response to K depolarization in P311 mice ( Figure 1E ). Consisently, P311 resisance arteries also showed decreased contractility in response to K and to vasoconsriction agoniss (norepinephrine, phenylephrine, epinephrine, and angiotensin II), with no diference in the vasodilatation response to hydralazine ( Figure 1E Figure 1F ). Collagen gel contraction assays showed that
VSMCs isolated from P311 aortas were less efcient in contracting collagen gels than those derived from WT animals, but their contraction upregulated Tgfb1, Tgfb2, and Tgfb3 mRNA levels in aortic tissues isolated from P311 mice, ELISA showed that total and active protein levels of the 3 isoforms were severely decreased in tissue extracts and in plasma samples from P311 mice (Figure 2 , A-C). Immunoblot analyses -/-
demonsrated reduced expression of pro-TGF-β1, pro-TGF-β2, pro-TGF-β3, and LAP-1 ( Figure 2D ). We found that blocking TGF-β activity resulted in a decrease in the contractile response of WT and P311 mouse-derived resisance arteries. This decrease was satisically signifcant only in the WT arteries, which had more TGF-β than their P311 counterparts ( Figure 2E ). VSMCs cultures also showed increased Tgfb1, Tgfb2, and Tgfb3 mRNA levels, while protein levels were decreased (Supplemental Figure 5 , A and B). Consisent with these fndings, phosphorylation of the transcriptional coregulators Smad2 and Smad3 was also decreased ( Figure 2F ). Mice carrying an active TGF-β reporter consruct, CAGA /GFP, showed lower activity in P311 versus P311 animals ( Figure 2G ). P311 VSMCs isolated from CAGA /GFPtransgenic mouse aortas also showed a loss of TGF-β activity relative to WT controls (Supplemental Figure 5C ). combined with the decrease in TGF-β isoform levels, suggesed that P311 regulates TGF-β translation, degradation, or both. Since we previously found that P311 binds to LAP (6), we frs considered the possibility that P311 is involved in TGF-β degradation through the engagement of its PEST domain. Ubiquitin immunoprecipitation assays showed no diferences in ubiquitin-bound TGF-β between aortas from P311 and WT mice (Supplemental Figure 6 ). Luciferase untranslated region (UTR) expression vectors, including the 5′-and 3′-UTRs of TGF-β1, TGF-β2, or TGF-β3 ( Figure 3A ), demonsrated increased translation in P311 -derived VSMCs transfected with P311 compared with empty vector control ( Figure 3B ). Further analyses demonsrated that the simulatory efect of P311 on luciferase expression was confned to the 5′-UTR of the respective TGF-β isoforms ( Figure 3B ). RNA immunoprecipitation revealed enrichment of TGF-β 5′-UTR mRNAs in P311 -derived VSMCs transfected with P311 compared with shamtransfected VSMCs and other controls ( Figure 3C ). (TGF-β neighboring gene on chromosome 7), Actb, and Tuba1a.
Figure 2
Data represent mean ± SD. *P < 0.05, **P < 0.01, 1-way ANOVA.
Unless otherwise specifed, experiments were performed at leas 3 times.
Recombinant TGF-βs resore P311 mouse blood pressure as well as vascular muscle tone and contractility. In rescue experiments, P311 and WT mice were treated with a combination of TGF-β1, TGF-β2, and TGF-β3 (referred to herein as TGF-β1-3), delivered intraperitoneally at a dosage sufcient to correct the decrease in plasma levels of active TGF-β observed in P311 mice ( Figure 4A ). TGF-β1-3 adminisration
resored blood pressure as well as vascular tone, contractility, and RhoA activity in P311 mice (Figure 4 , B-E). Over a period of 10 days, TGF-β supplementation induced comparable hypertensive responses in P311
and WT mice, as determined by plethysmography ( Figure 4B ), despite TGF-β1-3 in plasma reaching higher levels in WT mice ( Figure 4A ).
Collagen gel contraction assays showed resoration of contractility in P311 VSMCs after TGF-β1-3 treatment ( Figure 4F ). When Data represent mean ± SD. *P < 0.05, **P < 0.01, 1-way ANOVA.
P311 overexpression increases the level and activity of pro-TGF-βs and
TGF-βs and causes hypertension in mice. P311-transgenic (P311 ) mice exhibited increased levels in all 3 pro-TGF-βs in aortic tissues, resulting in increased plasma levels of total and active TGF-β1, TGF-β2,
and TGF-β3 ( Figure 5, A and B ). Increased TGFβ activity was also confrmed in CAGA /GFP reporter mice ( Figure 5C ). Consisent with the increased TGF-β expression levels and activity, P311 mice developed sysolic and diasolic hypertension, as determined by plethysmography ( Figure 5D ).
Figure 5
Transgenic P311 P311 is overexpressed in human hypertensive arteries. P311 levels were assessed in arterial tissue recovered from normotensive and hypertensive patients. Real-time PCR showed increased P311 mRNA levels in aortic tissues from hypertensive males relative to sex-matched normotensive controls ( Figure 6A ). In addition, IHC analyses demonsrated higher P311 protein levels in both arteries and arterioles from hypertensive males compared with normotensive controls ( Figure   6B ). Consisent with these fndings, TGF-β levels were increased in arteries from hypertensive patients compared with normotensive controls, and so were the nuclear levels of Smad2 and Smad3 ( (15). However, consisent with a functional role for P311 in the brain, these P311 mice display learning and memory defects (15, 16) .
Since P311 is also expressed at high levels in VSMCs, we explored its potential role within the sysemic vasculature.
Wesern blot analysis and IHC confrmed the presence of P311 in mouse and human vascular muscle and its absence in the vasculature of P311
mice. Furthermore, IHC indicated that P311 expression was higher in arteries than in veins. Gross examination and morphometry Finally, VSMCs isolated from P311 aortas were less efcient in contracting collagen gels than those derived from WT animals, while contraction improved after P311 transfection, confrming that the functional abnormality resed on the vascular muscle itself and that P311
directly regulated VSMC contractility.
We and others have reported that P311 modulates TGFβ expression when transfected into NIH-3T3 fbroblass (1, 5, 6). Thus, we next determined the expression of TGF-β1, TGF-β2, and TGF-β3 in P311
and WT aortas. Interesingly, while Tgfb1, Tgfb2, and Tgfb3 mRNA levels were upregulated in aortic tissues isolated from P311 mice, total and active protein levels of the 3 isoforms were severely decreased in VSMCs as well as in plasma samples of these mice. The reduced TGF-β activity occurred at the level of pro-TGF-β1, pro-TGF-β2, and pro-TGF-β3 expression, with accompanying decreases in the corresponding levels of LAP, which noncovalently associates with mature TGFβ.
Consisent with these fndings, downsream targets of TGF-β signaling, Remarkably, TGF-β1-3 adminisration alone resored blood pressure, contractility, and RhoA activity in P311 mice. In a similar fashion, contractility was also resored in P311 VSMCs after treatment with the TGF-β1-3 cocktail. When adminisered individually, TGF-β1 and TGF-β3 exerted efects comparable to those observed with TGF-β1-3 (albeit less pronounced), whereas TGF-β2 had no efect. While prior sudies demonsrated a role for TGF-β1 in blood pressure regulation (29-31), this represents the frs insance in which the potential efect of TGF-β2
and TGF-β3 in blood pressure levels was assessed and the frs demonsration that TGF-β3 increased them.
To determine whether P311 can directly regulate TGFβ activity and vascular tone in vivo, we generated transgenic mice overexpressing P311. As predicted, P311 transgenic mice exhibited an increase in all 3 pro-TGF-β levels in aortic tissues, with increased TGF-β activity -as indicated by the CAGA /GFP reporter mice -resulting in increased plasma levels of total and active TGF-β1, TGF-β2, and TGF-β3, as recorded for human hypertension and TGF-β1 (32-34). Furthermore, the P311 transgenic mice developed hypertension, which indicates not only that P311 is needed to prevent hypotension, but that its increase is sufcient to cause high blood pressure.
The increase in TGF-β mRNAs in P311 mice, combined with the decrease in TGF-β isoforms observed, suggess that P311 regulates TGF-β at the postranscriptional level, acting at translation, degradation, or both. Ubiquitin immunoprecipitation assays ruled out diferences in degradation. However, when luciferase expression vectors were consructed that included the 5′ and 3′-UTRs of TGF-β1, TGF-β2 or TGF-β3, the luciferase protein was expressed at lower levels in P311 versus WT cells, which indicates that P311 regulates translation of TGF-βs. Further analyses demonsrated that the simulatory efect of P311 on luciferase expression was confned to the 5′-UTR of the respective TGF-β isoforms. In addition, RNA immunoprecipitation revealed enrichment of the TGF-β 5′-UTR mRNAs in VSMCs isolated from P311-transfected P311 mice compared with sham-transfected controls, consisent with a role for P311 in translation of TGF-βs. Since P311 has no RNA-binding motifs, the P311-mRNA interaction is likely to
be indirect through one or more yet-uncharacterized proteins. Hence, P311 controls TGF-β levels and/or activity by acting as the frs known regulator of its translational activity.
As P311 had not been previously linked to blood vessel homeosasis, we fnally considered the possibility that the protein plays a role in human hypertension. We assessed P311 levels in arterial tissue recovered from normotensive and hypertensive patients. Indeed, increased P311 mRNA levels were detected in aortic tissues from hypertensive males relative to sex-matched normotensive controls. In addition, IHC analyses confrmed higher P311 protein levels in both arteries and arterioles from hypertensive versus normotensive tissue. Although our sudies showed that increased P311 level per se led to hypertension, it is possible that the high P311 expression detected in arteries of hypertensive patients is, in part, the result of increased mechanical sress, since in previous sudies we found that mechanical tension induces P311 in embryonic mesenchymal cells (1). Taken together, these data support the conclusion that P311 plays a heretofore unrealized role in modulating hypertensive responses in humans.
TGF-β is known to act as a critical efector of blood pressure regulation (29-31). To date, however, the pathophysiologic control of TGFβdependent vascular tone has largely been confned to angiotensin II, whose action is in great part mediated by and TGF-β1 polymorphisms (39) (40) (41) (42) . Herein, we identifed P311 as a previously unrecognized major regulator of the TGF-β-vascular tone axis. In the absence of P311, total and active levels of TGF-β1, TGF-β2, and TGF-β3 decreased in vascular muscle and plasma, in tandem with decreased RhoA activity and increased MLCP activity, resulting in low vascular contractility, tone, and hypotension. These abnormalities were intrinsic to the vascular muscle, as opposed to resulting from lack of P311 in the nervous sysem. In contras, mice overexpressing P311 featured increased production of TGF-βs in the vascular musculature and increased circulating levels of TGF-β1, TGF-β2, and TGF-β3 as well as TGF-β activity in vivo, while displaying a hypertensive phenotype. These data, combined with the observed linkage of increased mRNA and protein levels of P311 in hypertensive humans, served to identify P311
as a new and potentially important efector of blood pressure regulation.
 Methods
Mice. Generation of P311 mice (C57BL/6 mice with deletion of the entire P311 coding region on both alleles) was described previously (15). Blood pressure determination by telemetry and plethysmography.
TA11PA-C10 telemetry devices (Data Sciences International) were implanted subcutaneously along the fanks of 8 P311 mice and 8 WT -/-12 12 +/+ -/-TG controls for chronic acquisition of blood pressure parameters and heart rate. The devices' catheters were placed with the tip at leas 2 mm into the aortic arch. Data from WT and P311 mice were collected for a 1-
week period and analyzed using Dataques A.R.T. software (supplied by Data Sciences International).
Plethysmographic blood pressure was recorded using an 8-channel
CODA noninvasive blood pressure acquisition sysem (Kent Scientifc)
following the manufacturer's protocol. Mice were placed in a clear acrylic resrainer with a built-in nose cone for at leas 30 minutes prior to obtaining pressure measurements. Sysolic, diasolic, and mean blood pressure as well as heart rate were recorded. Blood pressures were monitored on days 0, 3, 6, and 10 of TGF-β treatment sudies. Adminisration of recombinant TGF-βs. Mice were intraperitoneally injected with recombinant (r) human TGF-β1, rTGF-β2, rTGF-β3, or rTGF-β1-3 (R&D Sysems). Injections were given to mice once daily for 10 days at a dose of 250 ng (rTGF-β1, rTGF-β2, and rTGF-β3) or 100 ng of each (rTGF-β1-3). Before and after rTGF-β treatments, blood pressure was monitored, and echocardiography was performed (only for combined rTGF-β1-3 treatment). After 10 days of treatment, aortas were isolated for myography sudies, along with Wesern blot analysis or ELISA (see below).
Wire myography. Thoracic aortas and mesenteric resisance arteries were cut into rings approximately 2 mm in length, and contractility was measured with a DMT 610M multi-myograph sysem (DMT-USA Inc.).
Optimal tension was initially applied, and tissues were allowed to equilibrate for 1 hour in 5 ml physiological salt solution (PSS; containing -/- RhoA activity assay. GTP-bound (i.e., active) RhoA was isolated from aortas using a commercial kit (Millipore). Aortas from WT and P311 mice were lysed with Rho-binding lysis bufer (50 mM Tris, pH 7.2, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl with 10 μg/ml leupeptin, 10 μg/ml aprotinin, and 1 mM PMSF).
Lysates were clarifed by centrifugation, and active RhoA was For reporter assay, TGF-β1-3 5′-and 3′-UTR regions were cloned into pGL3-promoter frefy luciferase vector (Promega) to generate reporter consructs. P311 mouse VSMCs were plated on 6-well plates and transfected with the P311 expression vector, the reporter consructs, and renilla luciferase internal control vector pRL-SV40. 48 hours after cotransfection, the Dual-Luciferase Reporter Assay Sysem (Promega) was used to determine the ratio of frefy/renilla luciferase activity, as indicated by the manufacturer.
RNA immunoprecipitation. 48 hours after transfection with the P311 -/-expression consruct pCMV-Myc-P311 or empty vector, cells were lysed in lysis bufer (25 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5%
glycerol, pH 7.4) supplied with Halt Protease Inhibitor Cocktail (Thermo Scientifc). Cell lysates were subject to immunoprecipitation using anti-c-Myc agarose (A7470; Sigma-Aldrich). Agarose beads were washed 3 times in lysis bufer and resuspended in TRIZOL for RNA isolation. Gel-contraction sudies. Gel-contraction sudies were conducted using 5 ml of rat tail collagen I solution (2 mg/ml in 0.1% acetic acid) mixed with 1 ml of 10× DMEM and 1 ml of 0.1 N NaOH to neutralize the pH before adding 3 ml of trypsinized VSMCs (WT, P311 , and P311 expression vector-transfected P311 ; 3 × 10 cells/ml) in culture medium. The mixed collagen gel solution was cased in 60-mm culture plasic dishes (4 ml/dish). After incubation at 37°C for 30 minutes, polymerized gels were detached and covered with 4 ml DMEM with 10% FBS. Lattices were photographed after 7 days, and magnitudes of gel contraction were calculated. For treatment purposes, the polymerized gels were incubated with regular media containing rTGF-β1, rTGF-β2, rTGF-β3, or rTGF-β1-3 at a concentration of 10 ng/ml.
Wesern blotting analysis. Aorta lysates and cultured aortic VSMC lysates (20 μg total protein) were resolved on SDS-PAGE gels and transferred onto nitrocellulose membranes (BioRad) for immunoblotting analysis. Abs agains P311 ( 44, 45), TGF-βs, LAP-1 (R&D Sysems), c--/--/-5
